The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2022 | Bridging the gap between in vitro and in vivo models of amyloid formation
Vittorio Bellotti, MD, PhD, University of Pavia, Pavia, Italy, talks on the importance of developing better experimental models of amyloid formation that better represent the actual pathological events that occur in patients with amyloidosis. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
